ANDA 203106, held by Upsher Smith Labs. Potassium Chloride.
As of Nov 15, 2026, ANDA 203106 (Klor-Con), held by Upsher Smith Labs, was first approved by FDA on Jul 10, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 10, 2015 | Original application | Approved | None posted |
| Klor-Con8MEQ · capsule, extended release;oral | Potassium Chloride | Discontinued |
| Klor-Con10MEQ · capsule, extended release;oral | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
